WASHINGTON/NEW YORK, April 27 (Reuters) - Activist investor
William Ackman promised U.S. lawmakers on Wednesday that he will
urge the board of Valeant Pharmaceuticals to reduce the
high prices of four life-saving drugs that are now at the heart
of two congressional probes.
Read more
No comments:
Post a Comment